rs757507674

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP3

The NM_000719.7(CACNA1C):​c.1823C>A​(p.Thr608Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T608I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

4
10
5

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.74

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_000719.7
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.794

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.1913C>A p.Thr638Asn missense_variant Exon 13 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.1988C>A p.Thr663Asn missense_variant Exon 14 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.1913C>A p.Thr638Asn missense_variant Exon 13 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.1913C>A p.Thr638Asn missense_variant Exon 13 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.1913C>A p.Thr638Asn missense_variant Exon 13 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.1913C>A p.Thr638Asn missense_variant Exon 13 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.1898C>A p.Thr633Asn missense_variant Exon 14 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.1898C>A p.Thr633Asn missense_variant Exon 14 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.1814C>A p.Thr605Asn missense_variant Exon 13 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.1823C>A p.Thr608Asn missense_variant Exon 13 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*430C>A non_coding_transcript_exon_variant Exon 11 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*430C>A 3_prime_UTR_variant Exon 11 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000803
AC:
2
AN:
249064
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.000128
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461492
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727034
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000597
AC:
2
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86190
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111758
Other (OTH)
AF:
0.00
AC:
0
AN:
60366
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00000037155), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
CardioboostArm
Benign
0.000026
BayesDel_addAF
Uncertain
0.013
T
BayesDel_noAF
Uncertain
0.020
CADD
Uncertain
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.62
D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.95
D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.79
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
0.94
.;L;.;L;L;L;L;L;L;L;L;L;L;L;L;L;.;L;L;L;.;.;.
PhyloP100
2.7
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-2.6
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.69
Sift
Benign
0.13
T;T;D;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.099
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
1.0, 0.99, 0.91, 0.98, 0.79, 0.95, 1.0, 1.0, 1.0
.;D;D;P;D;P;D;D;D;P;D;D;D;D;D;D;.;D;D;.;.;.;D
Vest4
0.74
MutPred
0.60
.;Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);Gain of catalytic residue at L605 (P = 2e-04);
MVP
0.89
MPC
2.0
ClinPred
0.63
D
GERP RS
5.3
gMVP
0.96
Mutation Taster
=20/80
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757507674; hg19: chr12-2676888; API